These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34155478)

  • 41. Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7.
    Jiang JQ; Huang JT; Zhong BY; Wang WD; Sun JH; Wang Q; Ding WB; Ni CF; Zhu XL
    J Hepatocell Carcinoma; 2023; 10():1629-1638. PubMed ID: 37791066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis.
    Kim GH; Kim JH; Ko HK; Chu HH; Kim SH; Shin JH; Gwon DI; Ko GY; Yoon HK; Kim KH; Shim JH; Kim N
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study.
    Wang L; Ke Q; Lin K; Chen J; Wang R; Xiao C; Liu X; Liu J
    Cancer Manag Res; 2020; 12():3815-3825. PubMed ID: 32547217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching].
    Ke Y; Zhong J; Guo Z; Liang Y; Li L; Xiang B
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):747-50. PubMed ID: 24844957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K
    AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517
    [No Abstract]   [Full Text] [Related]  

  • 47. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Sun T; Chen L; Kan X; Ren Y; Cao Y; Zhang W; Lu H; Zheng C
    J Oncol; 2022; 2022():1255133. PubMed ID: 35356254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy.
    An C; Zuo M; Li W; Chen Q; Wu P
    Front Oncol; 2021; 11():747496. PubMed ID: 34976800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
    Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma.
    Chen L; Sun T; Wu L; Zhang W; Ren Y; Xiang D; Liang B; Zheng C
    J Oncol; 2021; 2021():8169012. PubMed ID: 34840572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
    Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
    BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma.
    Wang X; Yuan Y; Wang J; Liu Z; Chen M; Zhou Q; Zhou Z
    J Cancer; 2021; 12(20):6231-6241. PubMed ID: 34539896
    [No Abstract]   [Full Text] [Related]  

  • 54. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
    Chai B; Wang W; Wang F; Zhou G; Zheng C
    Int J Hyperthermia; 2021; 38(1):1685-1694. PubMed ID: 34843653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion.
    Su TS; Li LQ; Meng WW; Wang YD; Chen YT; Li JX; Du YQ; Qu S; Zhao C; Huang DJ; Liang SX; Li LQ
    Front Oncol; 2020; 10():1205. PubMed ID: 32850352
    [No Abstract]   [Full Text] [Related]  

  • 57. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study.
    Guo P; Pi X; Gao F; Li Q; Li D; Feng W; Cao W
    Front Oncol; 2022; 12():945915. PubMed ID: 36338683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis.
    Zhang ZH; Hou SN; Yu JZ; Zhang W; Ma JQ; Yang MJ; Liu QX; Liu LX; Luo JJ; Qu XD; Yan ZP
    Front Oncol; 2022; 12():1086095. PubMed ID: 36741718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zhang YL; Nie CH; Chen F; Zhou TY; Zhou GH; Zhu TY; Chen SQ; Chen XH; Wang HL; Wang BQ; Yu ZN; Jing L; He ZM; Sun JH
    Front Oncol; 2020; 10():1754. PubMed ID: 32984060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.